ConductScience.org, home

Paper1964580

The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol.

Omvik P and 1 other. Cardiovasc Drugs Ther, 1990. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol. Papers, record 1964580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1964580

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol.
PubMed
Journal
Cardiovasc Drugs Ther
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2020-03-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Omvik PP
2Lund-Johansen PP

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
BenzeneacetamidesMajor topic
HemodynamicsMajor topic
Adult
Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers
Carbazoles
Carvedilol
Doxazosin
Female
Guanidines
Humans
Indoles
Labetalol
Male
Middle Aged
Nisoldipine
Pinacidil
Potassium Channels
Prazosin
Propanolamines
Propylamines
Receptors, Adrenergic, alpha
Receptors, Adrenergic, beta
Tiapamil Hydrochloride

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13365073The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.Arch Intern Med1988https://conductscience.org/library/papers/3365073PubMed
25021493Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.Am J Cardiol1972https://conductscience.org/library/papers/5021493PubMed
33472442Acute and chronic hemodynamic effects of nisoldipine in essential hypertension at rest and during exercise.Acta Med Scand Suppl1986https://conductscience.org/library/papers/3472442PubMed
46995298Hemodynamic and volume changes associated with captopril.Hypertension1980https://conductscience.org/library/papers/6995298PubMed
53351300Nisoldipine. Central haemodynamics at rest and during exercise in essential hypertension: acute and chronic studies.J Hypertens1988https://conductscience.org/library/papers/3351300PubMed
62857601Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.Clin Pharmacol Ther1985https://conductscience.org/library/papers/2857601PubMed
76587749Hemodynamic effects of verapamil in essential hypertension at rest and during exercise.Acta Med Scand Suppl1984https://conductscience.org/library/papers/6587749PubMed
86267618Presynaptic regulation of the release of catecholamines.Pharmacol Rev1980https://conductscience.org/library/papers/6267618PubMed
9232084Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.Hypertension1979https://conductscience.org/library/papers/232084PubMed
107387812Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7387812PubMed
116111532Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.Hypertension1981https://conductscience.org/library/papers/6111532PubMed
122466179Pinacidil-induced vascular relaxation: comparison to other vasodilators and to classical mechanisms of vasodilation.J Cardiovasc Pharmacol1988https://conductscience.org/library/papers/2466179PubMed
131555629Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.Eur Heart J1992https://conductscience.org/library/papers/1555629PubMed
145640885The paradox of beta-adrenergic blockade in hypertension.Circulation1968https://conductscience.org/library/papers/5640885PubMed
152939867Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2939867PubMed
162859740The first dose hemodynamic responses to Visacor (ICI 141-292) in essential hypertension.Acta Med Scand Suppl1985https://conductscience.org/library/papers/2859740PubMed
174334846Circulation: overall regulation.Annu Rev Physiol1972https://conductscience.org/library/papers/4334846PubMed
182414585Increased cardiovascular responses to norepinephrine and calcium antagonists in essential hypertension compared with normotension in humans.J Cardiovasc Pharmacol1985https://conductscience.org/library/papers/2414585PubMed
19793676Prazosin: the first-dose phenomenon.Br Med J1976https://conductscience.org/library/papers/793676PubMed
20205788Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.N Engl J Med1978https://conductscience.org/library/papers/205788PubMed

See all 29 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
38890192Adrenoceptors and Hypertension.Handb Exp Pharmacol2024https://conductscience.org/library/papers/38890192PubMed
8395198
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8395198PubMed
8097925
Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8097925PubMed
1350484Antihypertensive profile of carvedilol.Clin Investig1992https://conductscience.org/library/papers/1350484PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1964580

GET https://conductscience.org/api/papers/v1/1964580/references?page=2